
No. of Pages: 132 | Report Code: BMIRE00025498 | Category: Life Sciences
No. of Pages: 132 | Report Code: BMIRE00025498 | Category: Life Sciences
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Travel Vaccines Market – By Product
1.3.2 Europe Travel Vaccines Market – By Application
1.3.3 Europe Travel Vaccines Market – By Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 Europe PEST Analysis
4.3 Expert Opinion
5.1 Market Drivers
5.1.1 Significant Rise in Travel and Tourism
5.1.2 Growing Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 High Cost of Travel Vaccines
5.3 Market Opportunities
5.3.1 Awareness Regarding Vaccines
5.4 Future Trends
5.4.1 Significant Demand for Vaccines
5.5 Impact Analysis
6.1 Europe Travel Vaccines Marker Revenue Forecast and Analysis
7.1 Overview
7.2 Europe Travel Vaccines Market Revenue Share, by Product (2021 and 2028)
7.3 Hepatitis A
7.3.1 Overview
7.3.2 Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
7.4 Hepatitis B
7.4.1 Overview
7.4.2 Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
7.5 Meningococcal Vaccines
7.5.1 Overview
7.5.2 Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
8.1 Overview
8.2 Europe Travel Vaccines Market Revenue Share, by Application (2021 and 2028)
8.3 Domestic Travel
8.3.1 Overview
8.3.2 Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
8.4 Outbound Travel
8.4.1 Overview
8.4.2 Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
9.1 Overview
9.1.1 Europe: Travel Vaccines Market, by Country, 2020 & 2028 (%)
9.1.1.1 UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.1.1 UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.1.2 UK: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.1.3 UK: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
9.1.1.2 Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.2.1 Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.2.2 Germany: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.2.3 Germany: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
9.1.1.3 France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.3.1 France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.3.2 France: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.3.3 France: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
9.1.1.4 Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.4.1 Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.4.2 Italy: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.4.3 Italy: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
9.1.1.5 Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.5.1 Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.5.2 Spain: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.5.3 Spain: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
9.1.1.6 Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.6.1 Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
9.1.1.6.2 Rest of Europe: Travel Vaccines Market, by Product, 2019–2028 (US$ ‘Million)
9.1.1.6.3 Rest of Europe: Travel Vaccines Market, by Application, 2019–2028 (US$ ‘Million)
10.1 Overview
10.2 Growth Strategies in the Travel Vaccines Market, (%)
10.3 Organic Developments
10.3.1 Overview
10.4 Inorganic Developments
10.4.1 Overview
11.1 GlaxoSmithKline plc.
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Merck & Co., Inc.
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Sanofi
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 Novartis AG
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Pfizer Inc.
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Dynavax Technologies
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Emergent BioSolutions Inc.
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Abbott
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 Valneva SE.
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
12.1 About the Insight Partners
12.2 Glossary of Terms
Table 1. UK: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 2. UK: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 3. Germany: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 4. Germany: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. France: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. France: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Italy: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Italy: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Spain: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 10. Spain: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 11. Rest of Europe: Travel Vaccines Market, by Product – Revenue and Forecast to 2028 (US$ ‘Million)
Table 12. Rest of Europe: Travel Vaccines Market, by Application – Revenue and Forecast to 2028 (US$ ‘Million)
Table 13. Organic Developments Done by Companies
Table 14. Inorganic Developments Done by Companies
Table 15. Glossary of Terms, Europe Travel vaccines Market
Figure 1. Europe Travel Vaccines Market Segmentation
Figure 2. Europe Travel Vaccines Market – By Country
Figure 3. Europe Travel Vaccines Market Overview
Figure 4. Europe Outbound Segment Held Largest Share of Travel Vaccines Market by Product
Figure 5. France to Show Significant Growth During Forecast Period
Figure 6. Europe: PEST Analysis
Figure 7. Expert Opinion
Figure 8. Europe Travel Vaccines Market Impact Analysis of Drivers and Restraints
Figure 9. Europe Travel Vaccines Market – Revenue Forecast and Analysis – 2021- 2028
Figure 10. Europe Travel Vaccines Market Revenue Share, by Product (2021 and 2028)
Figure 11. Europe Hepatitis A: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 12. Europe Hepatitis B: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 13. Europe Meningococcal Vaccines: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 14. Europe Others: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 15. Europe Travel Vaccines Market Revenue Share, by Application (2021 and 2028)
Figure 16. Europe Domestic Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 17. Europe Outbound Travel: Travel Vaccines Market– Revenue and Forecast to 2028 (US$ Million)
Figure 18. Europe: Travel Vaccines Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 19. Europe: Travel Vaccines Market, by Country, 2020 & 2028 (%)
Figure 20. UK: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 21. Germany: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 22. France: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 23. Italy: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 24. Spain: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 25. Rest of Europe: Travel Vaccines Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 26. Growth Strategies in the Travel Vaccines Market, (%)